靶点针对疾病信息41(本栏目收费,不能显示细节,电话13136136841)
靶点针对疾病信息
INDICATI
Approved Urethral cancer [ICD-11: 2C93]
INDICATI
Phase 3 Brain cancer [ICD-11: 2A00]
INDICATI
Phase 3 Hypopharyngeal cancer [ICD-11: 2B6D]
INDICATI
Phase 3 Nasopharyngeal cancer [ICD-11: 2B6B]
INDICATI
Phase 2/3 Metastatic biliary tract neoplasms [ICD-11: 2C14-2C17]
INDICATI
Phase 2 Chronic pain [ICD-11: MG30]
INDICATI
Phase 2 Lymphoma [ICD-11: 2A80-2A86]
INDICATI
Phase 1/2 Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y]
INDICATI
Phase 1/2 Non-small cell lung cancer [ICD-11: 2C25]
INDICATI
Phase 1 Intracerebral haemorrhage [ICD-11: 8B00]
INDICATI
Phase 1 Mature B-cell leukaemia [ICD-11: 2A82]
INDICATI
Phase 1 Metastatic lymph node neoplasm [ICD-11: 2D60]
INDICATI
Phase 1 Spinal cord/cranial nerve neoplasm [ICD-11: 2A02]
INDICATI
Discontinued in Phase 2 Esophageal cancer [ICD-11: 2B70]
INDICATI
Terminated Digestive system disease [ICD-11: DE2Z]
INDICATI
Investigative Cerebral ischaemia [ICD-11: 8B1Z]
INDICATI
Investigative Cryptosporidiosis [ICD-11: 1A32]
INDICATI
Investigative Diffuse large B-cell lymphoma [ICD-11: 2A81]